24202-79-7

Basic information

• Product Name: 3-(METHOXYCARBONYL)ISONICOTINIC ACID
• Synonyms: 3-(METHOXYCARBONYL)ISONICOTINIC ACID;3,4-PYRIDINEDICARBOXYLIC ACID, 3-METHYL ESTER
• CAS NO: 24202-79-7
• Molecular Formula: C₈H₇NO₄
• Molecular Weight: 181.15
• Mol File: 24202-79-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 432.5 °C at 760 mmHg
• Flash Point: 215.4 °C
• Appearance: /
• Density: 1.363 g/cm³
• CAS DataBase Reference: 3-(METHOXYCARBONYL)ISONICOTINIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(METHOXYCARBONYL)ISONICOTINIC ACID(24202-79-7)
• EPA Substance Registry System: 3-(METHOXYCARBONYL)ISONICOTINIC ACID(24202-79-7)

Safety Data

• Hazardous Substances Data: 24202-79-7(Hazardous Substances Data)

Usage

General Description

3-(Methoxycarbonyl)isonicotinic acid is a chemical compound with the molecular formula C9H7NO5. It is a derivative of isonicotinic acid, and it is commonly used in the synthesis of pharmaceuticals and organic compounds. 3-(METHOXYCARBONYL)ISONICOTINIC ACID is a white crystalline powder that is sparingly soluble in water. It is primarily used in the pharmaceutical industry for the production of various drugs and pharmaceutical intermediates. 3-(Methoxycarbonyl)isonicotinic acid is also used as a building block in organic synthesis for the formation of complex organic molecules. It is an important compound in the field of medicinal chemistry and drug development.

Upstream product

• 67-56-1 methanol 
• 4664-08-8 cinchomeronic anhydride 
• 490-11-9 3,4-pyridinecarboxylic acid 
• 1796-83-4 dimethyl 3,4-pyridinedicarboxylate 

Downstream Products

• 81113-13-5 3-Hydroxymethyl-isonicotinic acid 
• 110-86-1 pyridine 
• 93-60-7 methyl 3-pyridinecarboxylate 
• 490-11-9 3,4-pyridinecarboxylic acid 
• 24202-74-2 4-(methoxycarbonyl)nicotinic acid 

Relevant articles and documents

NON-PEPTIDE OPIOID RECEPTOR MODULATORS

Non-peptide MOR opioid receptor modulators are provided. The compounds exhibit predominantly central activity and are used to treat e.g. opioid addiction. The compounds described herein are generally delivered (administered) in a pharmaceutical compositio

HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

Synthesis of the Pyridine Analogues of Phthalide

Routes for the preparation of the four isomeric pyridine analogues of phthalide are described starting from the readily available pyridine 2,3- and 3,4-diacids, or derivatives, and making use of the differential reactivity of substituents at pyridine 2- versus 3- and 3- versus 4-positions.